No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
300 |
4. Check minimum number of eventsNone |
300 |
5. Include endpointsNone |
300 |
6. Filter based on genotype QC (FinnGen only) |
300 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M21
- Name in latin
- Aliae deformitates acquisitae tarsi et pedis
Similar endpoints
↥List of similar endpoints to
Other acquired deformities of ankle and foot
based on the number of shared cases.
Similar with more cases:
- Other joint disorders
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2070 | 1328 | 732 |
| Only index persons | 1951 | 1272 | 679 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.04 | 0.02 |
| Only index persons | 0.04 | 0.05 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 49.53 | 52.51 | 44.04 |
| Only index persons | 49.39 | 52.17 | 44.18 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 300 | 211 | 89 |
| Unadjusted period prevalence (%) | 0.06 | 0.07 | 0.04 |
| Median age at first event (years) | 52.07 | 51.52 | 53.38 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 258
- Matched controls
- 2579
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M21.6
ICD-10 Finland
Other acquired deformities of ankle and foot
10820.0
268.6
210
*
M19.0
ICD-10 Finland
Primary arthrosis of other joints
70.5
53.4
60
11
M17.1
ICD-10 Finland
Other primary gonarthrosis
26.1
52.3
74
39
7367A
ICD-9 Finland
Other acquired deformities of limbs, Other acquired deformities of ankle and foot
+∞
51.8
48
*
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
270.9
45.5
45
*
M20.1
ICD-10 Finland
Hallux valgus (acquired)
40.3
41.7
52
16
NHK30
NOMESCO Finland
Osteotomy or rotation osteotomy of first metatarsal or tarsal bone
+∞
37.4
35
*
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
+∞
34.1
32
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
15.2
31.8
54
44
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
+∞
29.8
28
*
NHK40
NOMESCO Finland
Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone
116.9
29.3
31
*
NHK99
NOMESCO Finland
Other operation on bone of ankle or foot
112.6
28.3
30
*
M25.5
ICD-10 Finland
Pain in joint
5.5
27.8
98
259
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
84.2
27.4
30
*
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
19.0
27.4
42
26
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
18.3
27.0
42
27
WX320
NOMESCO Finland
Spinalanesthesy
6.2
27.0
82
180
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
+∞
26.5
25
*
N02AX02
ATC
tramadol; systemic, rectal
3.9
22.7
132
547
NHG77
NOMESCO Finland
Arthroplasty of interphalangeal tarsal joint(s)
+∞
21.1
20
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.6
20.9
143
663
N03AX12
ATC
gabapentin; oral
5.4
20.2
66
153
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
31.9
20.1
26
9
M20.2
ICD-10 Finland
Hallux rigidus
+∞
20.0
19
*
L17
ICPC
Foot/toe symptom/complaint
4.0
19.4
95
330
M16.1
ICD-10 Finland
Other primary coxarthrosis
59.8
19.2
22
*
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
23.0
19.1
27
13
NHU20
NOMESCO Finland
Removal of internal fixation device from ankle or foot
15.1
18.8
31
23
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
204.1
18.8
19
*
M01AX05
ATC
glucosamine; oral
4.9
18.6
68
177
NHL68
NOMESCO Finland
Tenodesis, shortening or lengthening of tendon of foot
102.1
17.8
19
*
NHK10
NOMESCO Finland
Incision or excision of metatarsal or tarsal bone
192.5
17.7
18
*
M22.4
ICD-10 Finland
Chondromalacia patellae
+∞
16.8
16
*
M01AH05
ATC
etoricoxib; oral
3.1
16.6
161
901
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
14.1
16.6
28
22
M79.6
ICD-10 Finland
Pain in limb
3.3
16.4
112
491
L15
ICPC
Knee symptom/complaint
4.3
16.2
67
195
9271
FHL
Hallux surgery
169.7
15.7
16
*
N03AX16
ATC
pregabalin; oral
3.7
15.5
80
279
M77.4
ICD-10 Finland
Metatarsalgia
9.1
14.8
31
38
M09AX01
ATC
hyaluronic acid; parenteral
16.7
14.7
23
15
N02AJ06
ATC
codeine and paracetamol; systemic
3.0
14.7
109
499
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
29.1
14.5
19
7
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
21.5
14.0
20
10
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
9.4
13.7
28
33
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
19.6
13.6
20
11
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
147.3
13.6
14
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
3.6
12.8
64
217
M13.9
ICD-10 Finland
Arthritis, unspecified
18.5
12.7
19
11
NHG26
NOMESCO Finland
Fusion between bones of ankle or ankle and foot
+∞
12.6
12
*
M19.2
ICD-10 Finland
Other secondary arthrosis
+∞
12.6
12
*
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
+∞
12.6
12
*
N02BE01
ATC
paracetamol; systemic, rectal
3.5
12.3
227
1746
9102
FHL
Trepanation or removal of the local bone process
49.1
12.0
14
*
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
6.5
11.9
31
53
ZXA05
NOMESCO Finland
Left side
3.1
11.9
78
320
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
6.0
11.6
32
59
M20.5
ICD-10 Finland
Other deformities of toe(s) (acquired)
125.3
11.5
12
*
B01AB05
ATC
enoxaparin; parenteral
2.9
11.4
83
362
M01AE02
ATC
naproxen; oral, rectal
2.5
11.3
153
951
M01AX17
ATC
nimesulide; oral
3.1
11.3
72
287
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.6
10.9
52
169
L16
ICPC
Ankle symptom/complaint
4.2
10.5
41
111
NHG82
NOMESCO Finland
Fusion of other tarsal joint
114.4
10.5
11
*
NHG22
NOMESCO Finland
Fusion of subtalar joint
114.4
10.5
11
*
G57.6
ICD-10 Finland
Lesion of plantar nerve
16.9
10.5
16
10
9351
FHL
Metatarsus osteotomies
+∞
10.5
10
*
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
34.0
10.4
13
*
M01AH01
ATC
celecoxib; oral (coxibs)
3.3
10.3
56
200
L28
ICPC
Limited function/disability (L)
3.5
10.2
50
165
J01FF01
ATC
clindamycin; systemic
2.7
10.1
84
393
9273
FHL
Other surgery for toe deformity or pain condition, e.g., Morton, hammer toe
41.8
10.0
12
*
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
7.9
9.9
22
30
SPAT1229
SPAT
Assessment of need for aid
5.1
9.9
31
67
NG2AA
NOMESCO Finland
Patella X-ray examination
57.2
9.7
11
*
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
6.7
9.6
24
39
S18
ICPC
Laceration/cut
2.4
9.6
110
612
P01BA02
ATC
hydroxychloroquine; oral
8.6
9.5
20
25
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.3
9.5
35
90
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
31.3
9.5
12
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
103.6
9.5
10
*
L90
ICPC
Osteoarthrosis of knee
9.2
9.5
19
22
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.7
9.5
42
128
7177A
ICD-9 Finland
Internal derangement of knee, Chondromalacia of patella
+∞
9.4
9
*
M17.3
ICD-10 Finland
Other post-traumatic gonarthrosis
+∞
9.4
9
*
7350A
ICD-9 Finland
Acquired deformities of toe, Hallux valgus (acquired)
+∞
9.4
9
*
NHL14
NOMESCO Finland
Shortening or lengthening of achilles tendon
+∞
9.4
9
*
NHG24
NOMESCO Finland
Fusion of subtalar joint and between bones of ankle
+∞
9.4
9
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
9.2
81
388
M19.9
ICD-10 Finland
Arthrosis, unspecified
13.2
9.0
15
12
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
7.6
8.9
20
28
ZXA00
NOMESCO Finland
Right side
2.6
8.9
71
324
M17
ICD-10 Finland
Gonarthrosis [arthrosis of knee]
5.1
8.7
27
58
TNX39
NOMESCO Finland
Other orthopedic bandage, unspecified region
20.9
8.5
12
6
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
11.3
8.4
15
14
NHK68
NOMESCO Finland
Shortening or lengthening osteotomy of ankle or foot
+∞
8.4
8
*
NF1DA
NOMESCO Finland
X-ray of hips
+∞
8.4
8
*
M01AE01
ATC
ibuprofen; systemic, rectal
3.1
8.3
234
1956
M02AA07
ATC
piroxicam; topical
2.3
8.1
95
523
M48.0
ICD-10 Finland
Spinal stenosis
3.9
8.1
33
94
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
7.0
8.0
19
29
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.4
7.9
80
410
TNX92
NOMESCO Finland
Supporting bandage or orthosis of lower limb
11.3
7.9
14
13
L13
ICPC
Hip symptom/complaint
3.2
7.9
43
152
M54.5
ICD-10 Finland
Low back pain
2.3
7.8
88
473
X58
ICD-10 Finland
Exposure to other specified factors
3.3
7.8
39
131
A02BC05
ATC
esomeprazole; systemic
2.2
7.7
107
635
ACC51
NOMESCO Finland
Release of median nerve
4.7
7.7
25
57
J01MA02
ATC
ciprofloxacin; systemic
2.2
7.7
102
594
NH1AD
NOMESCO Finland
Ankle and foot CT
12.4
7.7
13
11
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.1
7.6
29
78
L03
ICPC
Low back symptom/complaint
2.4
7.5
69
335
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
13.9
7.5
12
9
WX111
NOMESCO Finland
Local infiltration anesthesia
82.3
7.5
8
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
82.3
7.5
8
*
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
+∞
7.3
7
*
73799
ICD-8 Finland
Hallux valgus and varus
+∞
7.3
7
*
M21.5
ICD-10 Finland
Acquired clawhand, clubhand, clawfoot and clubfoot
+∞
7.3
7
*
NGE10
NOMESCO Finland
Incision or suture of capsule of knee joint
+∞
7.3
7
*
NHG70
NOMESCO Finland
Arthroplasty of first tarsometatarsal joint
+∞
7.3
7
*
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
16.3
7.3
11
7
L08
ICPC
Shoulder symptom/complaint
2.7
7.2
54
234
A02BC02
ATC
pantoprazole; systemic
2.1
7.2
161
1150
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
12.5
7.1
12
10
1220
FHL
Arthroscopy
10.5
7.1
13
13
L84
ICD-10 Finland
Corns and callosities
7.3
7.1
16
23
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.1
7.0
104
629
J01DA01
ATC
[U] cefalexin; systemic
2.0
7.0
165
1197
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
5.3
7.0
20
40
TQW40
NOMESCO Finland
Remowal of suture of skin
4.6
6.9
23
54
A07EC01
ATC
sulfasalazine; oral, rectal
7.0
6.9
16
24
XA402
NOMESCO Finland
ENMG
11.4
6.9
12
11
M01AH02
ATC
rofecoxib; oral
3.1
6.8
38
136
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
41.1
6.8
8
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
41.1
6.8
8
*
R03AC02
ATC
salbutamol; inhalant
2.0
6.8
136
924
ACC19
NOMESCO Finland
Transcision of peripheral nerve: other or unspecified
23.2
6.7
9
*
H02AB06
ATC
prednisolone; systemic
2.0
6.5
112
714
J01DB01
ATC
cefalexin; oral
2.2
6.5
205
1651
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.2
6.5
23
58
Q66.7
ICD-10 Finland
Pes cavus
71.5
6.5
7
*
NHG20
NOMESCO Finland
Fusion of talocrural joint
71.5
6.5
7
*
G57.8
ICD-10 Finland
Other mononeuropathies of lower limb
71.5
6.5
7
*
NHL30
NOMESCO Finland
Suture or reinsertion of tendon of foot
14.8
6.4
10
7
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
11.4
6.4
11
10
B01AX06
ATC
[U] rivaroxaban; oral
+∞
6.3
6
*
7151F
ICD-9 Finland
Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]
+∞
6.3
6
*
NHA30
NOMESCO Finland
Exploration of joint of ankle or foot, arthroscopic
+∞
6.3
6
*
NDG60
NOMESCO Finland
Arthroplasty of first CMC joint
+∞
6.3
6
*
NHL99
NOMESCO Finland
Other operation on muscle or tendon of ankle or foot
+∞
6.3
6
*
WZA90
NOMESCO Finland
Other doctors statement
2.3
6.1
61
304
M01AC06
ATC
meloxicam; systemic, rectal
2.0
6.1
92
554
M01AB05
ATC
diclofenac; systemic, rectal
1.9
6.1
162
1201
M01AB55
ATC
diclofenac, combinations; oral
3.8
6.1
24
67
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
75
296
3.05
14.26
1.2
1.2
u/ml
76.1
1.3
0.67
27
109
(3026493) Urate [Moles/volume] in Serum or Plasma
97
496
2.41
10.73
2.1
2.3
umol/l
338.6
9542.5
3.31
80
436
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
72
321
2.64
10.64
1.3
1.2
iu/ml
26.5
14.6
0.67
15
95
(3013707) Erythrocyte sedimentation rate by Westergren method
227
1666
2.49
10.57
4.9
3.3
mm/h
12.0
11.4
0.21
208
1515
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
14
8.89
9.41
1.3
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
133
829
2.09
8.71
3.7
3.3
ng/l
31.9
43.0
0.43
89
562
(3044941) Cell count panel - Synovial fluid
11
13
8.75
8.51
1.1
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
94
523
2.16
8.20
2.3
2.0
mg/l
2.8
2.9
0.13
76
428
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
143
952
1.96
7.48
2.3
2.3
nmol/l
79.4
76.5
0.68
129
849
(40768797) Stomach Pathology biopsy report
63
308
2.32
7.46
1.3
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
100
588
2.05
7.44
2.9
3.1
ng/l
736.6
1042.7
1.18
88
502
(3042936) Bacteria identified in Isolate by Culture
57
267
2.40
7.43
2.2
1.8
—
—
—
0
0
(3019225) pH of Specimen
48
212
2.50
7.09
3.4
4.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
51
234
2.42
6.94
1.6
1.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
162
1146
1.90
6.87
6.2
5.4
e9/l
0.2
0.2
0.13
148
991
(3023368) Bacteria identified in Blood by Culture
94
557
2.00
6.75
3.7
3.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
156
1097
1.88
6.68
6.0
5.0
e9/l
0.0
0.0
0.91
143
934
(3037522) Nuclear Ab [Titer] in Serum
51
243
2.32
6.36
1.4
1.3
titre
1080.0
457.7
0.55
12
52
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
132
893
1.85
6.27
1.9
1.9
pmol/l
108.1
96.0
1.40
67
443
(3019198) Lymphocytes [#/volume] in Blood
158
1131
1.84
6.25
6.0
5.0
e9/l
1.8
2.0
0.84
144
986
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
277
2412
2.94
6.23
16.2
12.0
mg/l
22.6
23.8
0.22
241
1810
(3001604) Monocytes [#/volume] in Blood
154
1096
1.83
6.19
6.0
5.0
e9/l
0.6
0.6
0.41
142
936
(3037467) Urinalysis macro (dipstick) panel - Urine
204
1590
1.88
6.05
5.4
3.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
156
1120
1.82
6.04
7.8
6.5
mmol/l
1.2
1.2
0.00
142
951
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
142
994
1.81
5.96
3.6
3.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
146
1040
1.79
5.70
6.4
4.9
%
2.8
2.7
0.07
141
959
(3013826) Glucose [Moles/volume] in Serum or Plasma
175
1315
1.79
5.69
4.0
4.5
mmol/l
6.6
6.7
0.22
165
1222
(3032080) INR in Blood by Coagulation assay
125
863
1.77
5.34
8.7
7.6
inr
1.3
1.2
0.35
32
255
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
144
1036
1.75
5.33
5.2
5.5
mmol/l
1.2
1.2
0.08
131
942
(3022217) INR in Platelet poor plasma by Coagulation assay
49
248
2.17
5.27
13.9
19.2
inr
1.0
1.1
—
8
36
(3018010) Neutrophils/100 leukocytes in Blood
147
1069
1.74
5.19
6.7
4.9
%
57.7
57.5
0.10
142
998
(42870588) Differential panel, method unspecified - Blood
107
712
1.78
5.15
5.9
4.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
54
288
2.07
5.07
2.5
2.4
g/l
2.3
2.4
0.80
48
268
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
29
119
2.59
4.97
2.9
3.1
mmol/l
0.9
1.5
0.33
21
92
(3002030) Lymphocytes/100 leukocytes in Blood
147
1085
1.70
4.80
6.7
5.0
%
27.5
27.8
0.12
141
1010
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
54
296
2.01
4.70
4.5
3.9
%
35.2
32.1
0.98
34
195
(3021788) Differential panel - Synovial fluid
8
8
10.23
4.54
1.5
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
278
2498
2.54
4.51
18.0
13.8
mmol/l
139.5
139.7
0.38
272
2419
(3022948) Iron [Moles/volume] in Serum or Plasma
55
308
1.96
4.50
2.6
2.4
umol/l
12.7
14.0
0.68
48
284
(3023103) Potassium [Moles/volume] in Serum or Plasma
278
2504
2.50
4.37
18.1
14.0
mmol/l
4.0
4.0
0.67
271
2420
(3013512) EKG study
94
628
1.72
4.35
4.3
3.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
98
669
1.69
4.16
1.9
2.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
82
2.68
3.98
1.9
1.9
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
60
360
1.83
3.97
1.7
1.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
100
698
1.65
3.86
2.6
2.4
u/l
56.3
57.0
0.05
94
647
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
225
1916
1.70
3.82
4.8
3.9
pmol/l
14.8
14.8
0.05
207
1743
(3013650) Neutrophils [#/volume] in Blood by Automated count
169
1342
1.59
3.81
8.7
9.1
e9/l
4.2
4.1
0.24
154
1157
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
215
1810
1.66
3.81
7.7
7.2
u/l
76.2
77.8
0.30
205
1696
(3001122) Ferritin [Mass/volume] in Serum or Plasma
133
1000
1.59
3.77
2.7
2.6
ug/l
99.1
110.1
0.43
120
922
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
255
2264
1.84
3.55
5.7
4.6
mu/l
1.7
2.4
0.74
235
2066
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
19
75
2.64
3.54
2.0
1.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
78
521
1.67
3.53
1.6
1.4
nmol/l
19.8
21.5
0.45
68
436
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
46
264
1.88
3.49
2.3
2.4
%
21.0
23.1
0.55
37
233
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
251
2223
1.79
3.46
6.4
5.3
mmol/mol
40.5
39.6
0.68
236
2044
(3019309) Folate [Moles/volume] in Red Blood Cells
61
387
1.72
3.32
1.8
1.6
nmol/l
1276.9
1252.1
0.06
43
281
(3026008) Bacteria identified in Urine by Culture
102
739
1.58
3.30
3.9
2.9
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
19
4.85
3.26
1.1
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
259
2328
1.82
3.22
14.2
11.2
ml/min/173m2
83.5
82.3
0.38
225
1888
(3010813) Leukocytes [#/volume] in Blood
292
2769
3.04
3.21
24.1
17.7
e9/l
6.7
6.6
0.39
287
2682
(3023520) Reticulocytes [#/volume] in Blood
32
167
2.03
3.19
3.3
2.7
e9/l
67.2
72.8
0.46
25
122
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
44
3.04
3.17
1.2
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
74
502
1.63
3.13
2.0
2.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
80
554
1.61
3.11
1.4
1.3
u/ml
2.8
1.6
0.24
24
140
(1616796) Gas panel - Central venous blood
11
34
3.32
3.09
2.7
3.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
28
142
2.07
3.01
5.4
2.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
27
135
2.10
3.01
1.3
2.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
140
1119
1.47
2.75
4.4
3.5
estimate
0.0
0.0
0.00
28
192
(3024561) Albumin [Mass/volume] in Serum or Plasma
123
959
1.48
2.73
4.8
4.7
g/l
35.2
36.0
0.94
116
901
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
43
261
1.76
2.73
7.4
6.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
38
223
1.81
2.70
2.6
4.4
u/l
225.7
239.5
0.50
32
212
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
43
2.87
2.68
1.6
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
189
1612
1.47
2.59
3.2
2.9
u/l
51.1
43.2
0.33
178
1505
(3014051) Protein [Presence] in Urine by Test strip
12
44
2.80
2.58
4.1
2.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
185
1575
1.46
2.53
3.0
3.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
70
492
1.55
2.52
1.6
1.6
mg/l
1.1
1.0
0.10
47
362
(3012516) Albumin [Mass/volume] in Urine
83
610
1.50
2.43
3.1
3.2
mg/l
950.8
270.2
0.33
56
379
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
15
64
2.41
2.43
1.4
1.5
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
9
27
3.40
2.41
5.2
1.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
275
2565
1.87
2.36
15.8
11.2
—
—
—
0
0
(4010399)
30
171
1.84
2.35
1.3
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
65
458
1.54
2.31
1.8
1.7
pmol/l
438.5
450.4
0.12
54
389
(3009508) Creatinine [Moles/volume] in Urine
89
675
1.45
2.20
3.1
3.0
mmol/l
6.8
7.3
0.46
78
573
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
42
270
1.65
2.18
1.5
1.8
%
1.5
1.4
0.31
37
243
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
14
61
2.36
2.18
2.4
2.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
41
264
1.64
2.12
1.4
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
264
2450
1.65
2.10
4.8
4.1
mmol/l
4.7
4.8
0.39
247
2268
(3009261) Glucose [Presence] in Urine by Test strip
138
1140
1.39
2.09
4.4
3.5
estimate
0.0
0.0
0.50
29
191
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
0
57
0.00
2.07
0.0
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
25
141
1.84
2.04
3.6
4.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
29
172
1.76
2.02
3.8
3.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
19
98
2.00
2.00
3.3
2.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
7
21
3.39
1.97
1.9
1.3
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
21
3.39
1.97
1.3
1.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
10
39
2.62
1.94
2.3
2.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
84
646
1.42
1.91
3.6
3.9
mg/mmol
10.1
8.3
0.14
53
406
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
34
2.70
1.88
1.2
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
6
17
3.58
1.84
1.2
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
135
1129
1.36
1.83
5.6
4.8
estimate
0.0
0.0
0.50
30
191
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
5
12
4.22
1.83
1.0
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
266
2491
1.60
1.82
5.2
4.6
mmol/l
2.8
2.9
0.86
249
2294
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
29
2.81
1.80
1.4
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
258
2402
1.53
1.79
4.8
4.1
mmol/l
6.0
5.9
0.26
235
2183
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
253
2348
1.49
1.76
4.3
3.7
mmol/l
1.3
1.3
0.30
235
2153
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
278
2636
1.74
1.75
11.9
9.1
u/l
25.7
25.7
0.03
267
2536
(3000850) Epithelial cells [#/volume] in Urine
61
450
1.45
1.73
2.7
2.4
e6/l
7.1
7.9
0.12
53
395
(3027945) Reticulocytes/100 erythrocytes in Blood
35
229
1.60
1.72
3.1
2.5
%
1.6
1.8
0.47
30
210
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
28
173
1.68
1.71
1.3
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
36
238
1.58
1.70
1.7
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
59
434
1.45
1.70
1.9
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
35
232
1.58
1.64
1.8
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
65
491
1.41
1.62
4.6
4.7
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
5
14
3.61
1.62
17.4
7.6
mmol/l
0.6
0.7
—
5
14
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
22
129
1.76
1.61
1.5
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
13
64
2.08
1.56
1.0
1.0
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
8
33
2.46
1.55
2.8
3.2
kpa
5.2
5.2
—
8
33
(3027315) Oxygen [Partial pressure] in Blood
8
33
2.46
1.55
2.8
3.2
kpa
8.5
8.8
—
8
33
(3015377) Calcium [Moles/volume] in Serum or Plasma
99
807
1.34
1.54
3.1
3.9
mmol/l
2.4
2.4
0.10
81
720
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
259
2432
1.48
1.52
4.9
4.1
mmol/l
1.5
1.5
0.26
241
2236
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
65
2.05
1.51
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
37
2.48
1.49
1.2
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
28
181
1.60
1.46
2.7
2.6
ug/l
8.4
7.2
0.16
23
161
(3010726) Horse dander IgE Ab [Units/volume] in Serum
7
28
2.53
1.46
1.0
1.0
—
8.8
—
0
5
(3029937) Albumin [Presence] in Urine by Test strip
75
591
1.36
1.45
4.9
3.9
estimate
0.0
0.0
0.50
29
189
(3045414) Leukocytes [Presence] in Urine
16
88
1.86
1.44
3.3
1.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
39
2.35
1.44
1.4
1.6
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
22
2.76
1.44
1.3
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
186
1669
1.30
1.40
4.1
3.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
117
989
1.30
1.39
2.0
2.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
96
791
1.31
1.37
4.0
3.4
e6/l
60.2
127.2
0.81
67
536
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
75
1.91
1.36
1.4
1.9
g/l
3.2
3.0
—
9
61
(3022145) Colonoscopy Study observation
37
261
1.48
1.33
1.3
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
35
2.32
1.28
2.6
3.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
25
2.43
1.25
1.2
1.9
pg
33.2
31.8
—
6
25
(3011397) Hemoglobin [Presence] in Urine by Test strip
65
514
1.34
1.23
5.1
3.6
—
—
—
0
0
(4146454)
5
19
2.66
1.22
5.8
2.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
26
2.33
1.19
1.3
1.5
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
34
242
1.46
1.18
1.3
1.4
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
33
0.00
1.17
0.0
3.9
—
3.3
—
0
33
(3007164) IgA [Mass/volume] in Serum or Plasma
59
465
1.33
1.14
1.6
1.4
g/l
2.9
2.2
0.60
35
288
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
30
2.36
1.13
1.3
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
26
177
1.51
1.12
5.7
4.5
%
1.2
1.2
—
5
53
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
81
1.76
1.11
1.4
1.9
g/l
4.1
3.5
—
9
61
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
81
1.76
1.11
1.4
1.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
14
81
1.76
1.11
1.4
1.9
g/l
8.4
7.4
—
9
63
(3019150) Specific gravity of Urine by Refractometry
63
504
1.32
1.10
5.5
3.7
kg/l
1.0
1.0
0.12
13
67
(3044927) Protein electrophoresis panel - Urine
5
21
2.40
1.09
1.0
1.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
94
794
1.27
1.09
3.4
2.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
82
684
1.27
1.05
3.5
2.8
e6/l
66.3
50.5
0.19
65
500
(36660697) Celiac disease serology panel - Serum
28
198
1.46
1.02
1.1
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
5
23
2.19
0.98
1.0
1.0
—
1.1
—
0
5
(3026389) Candida sp identified in Specimen by Organism specific culture
0
30
0.00
0.98
0.0
1.3
—
—
—
0
0
(3020891) Body temperature
14
85
1.68
0.96
3.6
4.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
14
85
1.68
0.96
6.3
4.7
%
1.6
1.6
0.01
14
77
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
51
1.79
0.95
1.0
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
82
694
1.25
0.93
4.9
3.8
ph
7.4
7.4
0.26
15
128
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
43
1.88
0.88
1.3
1.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
71
597
1.25
0.85
7.5
7.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
6
112
0.53
0.85
1.7
1.8
mg/l
3.2
2.8
—
6
84
(44790047)
6
31
1.95
0.85
1.2
1.4
—
—
—
0
0
(44790048)
6
31
1.95
0.85
1.2
1.4
—
—
—
0
0
(44790049)
6
31
1.95
0.85
1.2
1.4
—
—
—
0
0
(44806118)
6
31
1.95
0.85
1.2
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
21
147
1.46
0.82
1.1
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
32
1.89
0.82
1.0
2.0
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
17
114
1.52
0.81
3.1
5.8
mmol/l
25.9
25.6
0.18
17
114
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
33
1.83
0.79
1.0
1.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
38
298
1.32
0.79
2.6
2.2
ug/g
126.9
125.0
0.01
33
227
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
27
0.00
0.78
0.0
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
6
34
1.78
0.76
1.0
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
13
83
1.59
0.76
6.2
4.9
%
0.9
0.9
0.06
13
76
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
133
1.46
0.75
1.2
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
171
0.63
0.74
1.4
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
39
1.81
0.73
1.3
1.1
—
—
—
0
0
(4094501)
10
60
1.69
0.73
1.4
1.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
100
885
1.19
0.73
4.8
3.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
30
231
1.33
0.71
4.2
7.3
mmol/l
1.3
1.3
0.01
22
185
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
51
423
1.25
0.70
3.2
4.1
ng/l
126.6
259.1
0.51
42
322
(3017732) Neutrophils [#/volume] in Blood
20
144
1.42
0.70
3.0
2.5
e9/l
3.4
4.0
0.68
13
120
(3011288) Drugs identified in Urine by Screen method
10
61
1.66
0.69
1.8
2.1
—
—
—
0
0
(3036489) Thrombin time
5
92
0.54
0.68
1.4
2.0
s
22.8
21.3
—
5
85
(3041096) Erythrocytes [Presence] in Urine by Automated
73
636
1.20
0.63
3.5
3.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
114
1033
1.17
0.62
10.7
8.1
e9/l
0.0
0.0
0.71
95
835
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
50
1.62
0.62
1.1
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
52
1.55
0.60
1.4
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
32
257
1.27
0.58
1.8
1.9
—
—
—
0
0
(3039000) Anion gap in Blood
8
54
1.49
0.57
2.9
6.6
mmol/l
12.6
10.5
—
8
48
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
54
1.49
0.57
1.1
1.5
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
8
54
1.49
0.57
2.9
6.6
mmol/l
104.6
105.5
—
8
48
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
32
258
1.27
0.57
1.7
1.8
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
65
1.56
0.56
2.1
2.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
82
1.48
0.55
1.8
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
39
1.55
0.53
1.3
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
38
318
1.22
0.50
1.9
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
20
154
1.32
0.50
1.6
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
48
1.47
0.47
1.4
2.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
23
185
1.26
0.43
1.2
1.2
iu/ml
18.5
154.1
6.58
14
72
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
21
260
0.79
0.42
3.7
4.5
ug/l
4.2
35.5
0.66
15
221
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.3
—
2.1
—
0
15
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
0
15
0.00
0.41
0.0
1.8
—
1.3
—
0
10
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
59
1.37
0.41
1.1
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
16
0.00
0.41
0.0
3.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
17
0.00
0.41
0.0
2.5
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
17
0.00
0.41
0.0
3.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
5
34
1.48
0.40
1.0
1.2
u/l
23.6
15.1
—
5
27
(3026782) Osmolality of Urine
50
440
1.16
0.40
2.5
2.6
mosm/kgh2o
450.4
541.9
2.01
39
373
(3000330) Specific gravity of Urine by Test strip
15
115
1.32
0.39
3.7
3.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
35
1.44
0.39
1.4
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
66
1.37
0.38
1.2
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
36
1.40
0.38
1.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
113
0.70
0.38
2.1
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
51
452
1.15
0.38
1.1
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
9
69
1.31
0.37
4.1
3.0
mmol/l
3.8
3.9
—
9
64
(3030467) Casts [#/volume] in Urine by Automated count
68
616
1.13
0.37
3.6
2.9
e6/l
0.4
0.6
0.32
53
445
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
22
180
1.24
0.37
2.6
3.2
ml/min/173m2
70.8
64.1
—
9
71
(3018677) aPTT in Platelet poor plasma by Coagulation assay
41
358
1.17
0.36
2.0
1.7
s
29.4
29.5
0.04
41
350
(3013139) Helicobacter pylori Ag [Presence] in Stool
20
163
1.24
0.35
1.6
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
15
187
0.79
0.33
3.8
3.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
18
146
1.25
0.33
1.3
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
24
283
0.83
0.32
2.5
2.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
51
458
1.14
0.32
5.4
4.2
ug/l
2.6
3.0
0.14
46
417
(3009542) Hematocrit [Volume Fraction] of Blood
234
2280
1.12
0.32
15.8
13.1
%
39.9
40.1
0.12
162
1709
(3003694) ABO and Rh group [Type] in Blood
60
655
0.90
0.29
1.3
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
12
95
1.27
0.26
1.4
1.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
73
1.24
0.25
1.3
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
14
114
1.24
0.25
2.5
2.5
%
0.6
0.7
0.19
14
107
(3028300) Cannabinoids [Presence] in Urine
12
96
1.26
0.25
1.4
1.7
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
23
264
0.86
0.24
6.0
5.3
mmol/l
102.9
103.8
0.30
23
257
(3000492) Spirometry study
24
209
1.16
0.23
1.6
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
38
1.32
0.23
1.8
1.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
39
1.29
0.23
2.0
4.9
—
4148.3
—
0
6
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
5
39
1.29
0.23
1.2
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
7
94
0.74
0.22
1.0
1.3
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
40
1.25
0.22
2.0
2.3
%
72.6
63.9
—
5
40
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
42
383
1.11
0.22
3.1
2.4
e6/l
0.9
1.1
0.21
21
191
(3037756) Immunofixation for Serum or Plasma
5
41
1.22
0.22
1.4
2.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
41
1.22
0.22
1.0
1.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
10
124
0.80
0.22
5.7
8.6
%
0.7
0.7
—
10
124
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
10
124
0.80
0.22
5.7
8.5
%
1.5
1.5
—
10
124
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
107
1.22
0.22
2.5
2.4
—
—
—
0
0
(1002224) Polysomnography panel
8
101
0.79
0.21
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(4198724)
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
240
0.87
0.21
1.5
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
89
1.24
0.21
1.6
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
11
89
1.24
0.21
1.5
1.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
24
271
0.88
0.21
1.3
1.4
—
—
—
0
0
(4027681)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
1383.8
—
0
13
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
22
250
0.87
0.20
2.5
2.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
18
208
0.86
0.20
2.1
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
44
404
1.10
0.20
2.1
1.8
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
0
14
0.00
0.20
0.0
1.0
—
1.4
—
0
14
(3028707) Methadone [Presence] in Urine by Screen method
6
49
1.23
0.20
1.7
1.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
16
137
1.18
0.19
3.7
3.0
g/l
130.4
126.8
0.38
16
131
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
7
61
1.15
0.17
1.1
2.0
g/l
0.0
0.0
—
7
56
(3050129) First trimester maternal screen panel - Serum or Plasma
5
66
0.75
0.17
1.4
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
68
1.18
0.16
1.1
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
12
141
0.84
0.16
1.9
1.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
8
70
1.15
0.16
1.1
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
15
130
1.16
0.16
1.1
1.2
titre
—
5.2
—
0
5
(3033658) Prothrombin time (PT) actual/Normal
55
583
0.93
0.15
4.0
3.4
%
88.9
93.4
0.68
55
571
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
106
0.84
0.13
2.2
2.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
200
0.89
0.13
3.9
3.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
95
1.16
0.12
1.5
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
94
910
1.05
0.11
2.3
2.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
105
1.15
0.11
4.3
10.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
20
183
1.10
0.10
3.3
7.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
39
369
1.07
0.10
3.2
2.5
e6/l
1.1
2.8
2.49
20
177
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
44
1.14
0.10
1.4
1.4
—
—
—
0
0
(4035726)
24
223
1.08
0.09
1.7
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
134
0.89
0.09
1.2
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
65
1.08
0.08
1.6
2.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
7
66
1.06
0.08
1.1
1.2
g/l
1.1
1.2
—
7
60
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
74
1.08
0.07
1.6
1.5
—
—
—
0
0
(4034850)
7
80
0.87
0.07
4.4
6.8
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
63
612
1.04
0.06
3.6
2.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
39
375
1.05
0.06
4.8
3.8
%
22.0
21.9
0.01
19
168
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
59
607
0.97
0.06
1.8
1.6
mmol/l
1.3
1.4
0.33
52
495
(3025941) Bacteria identified in Stool by Culture
14
131
1.07
0.03
1.1
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
214
2127
1.02
0.03
20.4
15.9
g/l
331.8
332.3
0.37
214
2114
(3024354) Oxygen [Partial pressure] in Venous blood
17
178
0.95
0.02
4.5
2.6
kpa
4.6
4.6
0.01
17
168
(3027944) Amphetamines [Presence] in Urine
10
94
1.07
0.01
1.3
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
102
0.98
0.00
1.3
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
102
0.98
0.00
1.1
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
21
212
0.99
0.00
4.5
3.2
kpa
5.9
5.8
0.15
21
199
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
28
282
0.99
0.00
3.3
2.6
ug/l
0.8
0.9
0.25
18
181
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
97
1.03
0.00
1.3
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
32
316
1.01
0.00
1.3
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
64
0.94
0.00
1.3
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
8
0.00
0.00
0.0
2.8
—
125.5
—
0
8
(3024932) HLA-DR beta [Type]
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
7
0.00
0.00
0.0
1.4
—
17.1
—
0
7
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
9
0.00
0.00
0.0
1.0
—
124.0
—
0
9
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024471) HLA-A [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
4.1
—
0
7
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
8.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
11.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
5
0.00
0.00
0.0
8.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
18.0
—
0
5
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_ANKLEFOOT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_ANKLEFOOT | 0.955 [0.74, 1.23] | 0.72 |
| Birth year | 0.996 [0.99, 1.0] | 0.354 |
During the follow-up period (1.1.1998 — 31.12.2019), 83 out of 876 females with M13_ANKLEFOOT died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have M13_ANKLEFOOT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.109% | No data |
| 5 | 0.579% | No data |
| 10 | 1.411% | No data |
| 15 | 2.842% | No data |
| 20 | 5.145% | No data |
Relationships between endpoints
↥Index endpoint: M13_ANKLEFOOT – Other acquired deformities of ankle and foot
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data